Xeris Pharmaceuticals's market cap is currently $591.85M. The company's EPS TTM is $-0.438; its P/E ratio is ―; Xeris Pharmaceuticals is scheduled to report earnings on March 5, 2025, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 163.91M	$ 110.25M	$ 110.25M	$ 49.59M	$ 20.16M
Gross Profit	$ 135.27M	$ 87.61M	$ 87.61M	$ 36.27M	$ 10.83M
Operating Income	$ -44.01M	$ -81.94M	$ -81.94M	$ -115.16M	$ -83.55M
EBITDA	$ -23.73M	$ -69.31M	$ -113.67M	$ -80.08M	$ -117.80M
Net Income	$ -62.26M	$ -94.66M	$ -94.66M	$ -122.72M	$ -91.14M
Balance Sheet
Cash & Short-Term Investments	$ 72.45M	$ 121.97M	$ 121.97M	$ 102.43M	$ 133.79M
Total Assets	$ 322.60M	$ 344.52M	$ 344.52M	$ 304.36M	$ 159.15M
Total Debt	$ 229.19M	$ 198.06M	$ 198.06M	$ 88.07M	$ 87.02M
Net Debt	$ 161.74M	$ 76.09M	$ 76.09M	$ 20.80M	$ 49.42M
Total Liabilities	$ 329.38M	$ 299.33M	$ 299.33M	$ 209.13M	$ 125.39M
Stockholders' Equity	$ -6.78M	$ 45.19M	$ 45.19M	$ 95.23M	$ 33.76M
Cash Flow
Free Cash Flow	$ -49.29M	$ -103.42M	$ -103.42M	$ -96.62M	$ -80.94M
Operating Cash Flow	$ -47.02M	$ -102.89M	$ -102.89M	$ -95.53M	$ -80.56M
Investing Cash Flow	$ -6.00M	$ 34.46M	$ 34.46M	$ 97.96M	$ -27.41M
Financing Cash Flow	$ -1.61M	$ 127.47M	$ 127.47M	$ 27.25M	$ 126.06M

Currency in USD

Xeris Pharmaceuticals Earnings and Revenue History

Income Statement >

Xeris Pharmaceuticals Debt to Assets

Balance Sheet >

Xeris Pharmaceuticals Cash Flow

Cash Flow >

Xeris Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing